United Kingdom

People: Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

13 Sep 2019
Change (% chg)

$-0.06 (-1.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gibney, Anthony 

Mr. Anthony S. Gibney is Executive Vice President, Chief Business Officer of the Company. Prior to joining Achillion, Mr. Gibney was an investment banker for almost 25 years, completing over 150 merger and acquisition and financing transactions as a lead advisor to US and EU-based life science clients. Most recently, he was a Managing Director and Co-Head of the Biotechnology Investment Banking Team at Leerink Partners. Prior to that, Tony worked in the Healthcare Group at Merrill Lynch, Inc., where he ultimately led the East Coast Biotechnology origination effort as a Managing Director. Tony began his professional career as an analyst and associate in the Healthcare Investment Banking Group at Lehman Brothers Inc. Tony holds a Bachelor of Arts degree in History and Economics from Yale University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --